Chat with us, powered by LiveChat

Our news

Explore the latest news from Lhasa

Sign up to our newsletter

Lhasa Limited launches Consult Lhasa to provide expert scientific risk assessments worldwide

Lhasa Limited is proud to announce the launch of Consult Lhasa, a wholly owned Lhasa Limited subsidiary, dedicated to providing expert scientific risk assessments to the pharmaceutical industry.

Lhasa Limited unveils Mirabilis 4.2: A leap forward in customisation and control

Lhasa Limited is delighted to announce the release of Mirabilis 4.2, providing members with advanced customisation options, and a more streamlined user experience.

Empowering industry progression through collaborative data sharing

Lhasa Limited is delighted to announce the release of new data to its Vitic Aromatic Amines database users. The Aromatic Amines data sharing initiative is a collaboration of pharmaceutical organisations sharing data from Ames mutagenicity assays for primary aromatic amines.

Lhasa Limited release cutting-edge toxicity data to enhance chemical risk assessments

Lhasa Limited is delighted to announce the release of Vitic 2023.1.1, featuring updated genotoxicity, carcinogenicity, and sensitisation endpoints, designed to enhance chemical risk assessments.

Lhasa Limited release functionality to predict the carcinogenic potency of nitrosamines

In concordance with the latest regulatory guidance on establishing acceptable intake (AI) limits for N-Nitrosamines, Lhasa Limited is pleased to announce the addition of nitrosamine carcinogenic potency categorisation approach (CPCA) assessment functionality to the latest version of Derek Nexus!

Rapid expansion of the Nitrites database continues with latest data release

Lhasa Limited is delighted to announce the second release of new data to its Vitic Nitrites database users. The Nitrites data sharing initiative is a key part of our global response to the nitrosamine crisis.

Lhasa Limited and the EMA: A joint commitment to shared knowledge

Lhasa Limited announces their ongoing collaboration with the European Medicines Agency (EMA), welcoming them as members and users of all Lhasa software.

Vitic Intermediates data release announced to members

Lhasa Limited is delighted to announce the release of new data to its Vitic Intermediates database users. A database of Ames mutagenicity results for common intermediates, Vitic Intermediates is advancing the development of in silico predictive tools to support more accurate risk assessments.

Vitic Complex Nitrosamines database more than doubles in size since launch

Lhasa Limited is pleased to announce the third release of new data to Vitic Complex Nitrosamines database users, with the database more than doubling in size since its inception.

Lhasa Limited continues to expand in Latin America, welcoming members in Argentina, Colombia and Uruguay

Lhasa Limited, a leading global supplier of knowledge-based software solutions and associated databases, continues its expansion in Latin America with new members joining in Argentina, Colombia and Uruguay.